Keebeck Wealth Management, LLC Eli Lilly & CO Transaction History

Keebeck Wealth Management, LLC

$667 Million
Q3 2024

A detailed history of Keebeck Wealth Management, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Keebeck Wealth Management, LLC holds 8,146 shares of LLY stock, worth $6.09 Million. This represents 1.08% of its overall portfolio holdings.

Number of Shares

8,146

Previous 7,353 10.78%

Holding current value

$6.09 Million

Previous $6.66 Million 8.4%

% of portfolio

1.08%

Previous 0.99%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$772.14 - $960.02 $612,307 - $761,295	793 Added 10.78%	8,146 $7.22 Million
Q2 2024 Aug 14, 2024	SELL	$724.87 - $909.04 $16,672 - $20,907	-23 Reduced 0.31%	7,353 $6.66 Million
Q1 2024 May 14, 2024	SELL	$592.2 - $792.28 $59,812 - $80,020	-101 Reduced 1.35%	7,376 $5.74 Million
Q4 2023 Feb 14, 2024	BUY	$525.19 - $619.13 $167,010 - $196,883	318 Added 4.44%	7,477 $4.36 Million
Q3 2023 Nov 14, 2023	SELL	$434.7 - $599.3 $1.35 Million - $1.86 Million	-3,098 Reduced 30.2%	7,159 $3.85 Million
Q2 2023 Aug 14, 2023	BUY	$350.74 - $468.98 $446,842 - $597,480	1,274 Added 14.18%	10,257 $4.81 Million
Q1 2023 May 15, 2023	BUY	$310.63 - $364.82 $266,520 - $313,015	858 Added 10.56%	8,983 $3.08 Million
Q4 2022 Feb 14, 2023	BUY	$321.55 - $374.67 $117,687 - $137,129	366 Added 4.72%	8,125 $2.97 Million
Q3 2022 Nov 14, 2022	BUY	$296.48 - $337.87 $278,987 - $317,935	941 Added 13.8%	7,759 $2.51 Million
Q2 2022 Aug 15, 2022	BUY	$278.73 - $327.27 $245,839 - $288,652	882 Added 14.86%	6,818 $2.21 Million
Q1 2022 May 16, 2022	BUY	$234.69 - $291.66 $144,803 - $179,954	617 Added 11.6%	5,936 $1.7 Million
Q4 2021 Feb 14, 2022	BUY	$224.85 - $279.04 $67,455 - $83,712	300 Added 5.98%	5,319 $1.47 Million
Q3 2021 Nov 16, 2021	SELL	$221.6 - $272.71 $68,917 - $84,812	-311 Reduced 5.83%	5,019 $1.16 Million
Q2 2021 Aug 16, 2021	BUY	$180.55 - $233.54 $97,858 - $126,578	542 Added 11.32%	5,330 $1.22 Million
Q1 2021 May 13, 2021	BUY	$164.32 - $212.72 $18,896 - $24,462	115 Added 2.46%	4,788 $895,000
Q4 2020 Feb 16, 2021	BUY	$130.46 - $172.63 $19,960 - $26,412	153 Added 3.38%	4,673 $789,000
Q3 2020 Nov 02, 2020	BUY	$146.22 - $169.13 $91,387 - $105,706	625 Added 16.05%	4,520 $668,000
Q2 2020 Aug 06, 2020	BUY	$136.42 - $164.18 $234,369 - $282,061	1,718 Added 78.92%	3,895 $638,000
Q1 2020 May 14, 2020	SELL	$119.05 - $147.35 $2,738 - $3,389	-23 Reduced 1.05%	2,177 $301,000
Q4 2019 Feb 14, 2020	BUY	$106.92 - $132.43 $235,224 - $291,346	2,200 New	2,200 $288,000

Others Institutions Holding LLY

# of Institutions

4,004

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $711B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Keebeck Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Keebeck Wealth Management, LLC with notifications on news.

Account

Keebeck Wealth Management, LLC Eli Lilly & CO Transaction History